Our Approach

Our award-winning and patent-pending AllazoEngine predicts patients’ risk of medication non-adherence and identifies the intervention channels and messages that produce the highest uplift in adherence. 

Our engine leads the industry in accuracy, consistently achieving values as high as the mid 90’s.

Benefits to Our Customers

adherence uplift
per $ spent

Demonstrated by randomized controlled, intent-to-treat trial. Publication pending.

Get Connected